}}</ref>  Metofoline tablets were marketed in the United States under the brand name of Versidyne,<ref>{{cite journal | pmid = 13975764| year = 1963| author1 = Ryan| first1 = R. E.| title = Versidyne. Its use in vascular headache| journal = Headache| volume = 2| pages = 203â€“8}}</ref> but the drug was withdrawn from the market in 1965 due to the occurrence of [[Human eye|ophthalmic]] side-effects and the discovery that it could produce corneal opacities in dogs.<ref>''Federal Register'', March 27, 1965 (30 FR 4083).</ref>
